For US Healthcare Professionals

Sotalol IV Logo

Resources for Healthcare Providers

Whether you're learning about Sotalol IV for the first time or already administer it, we're here to support you.

Online Training

Get up to speed on Sotalol IV with an in-depth, interactive education and certification program.

Click here to enroll. Use code 218490 when prompted.

Already have an account? Log in here.

Sotalol IV Implementation Program

Account specialists and clinical professionals are ready to meet with you in-person at your institution and help support implementation. 

Reach out today and we’ll be in touch.

Product Information

Recommended dosing and protocol information, product sheets, and more available for download.

Research Publications

View a collection of published research papers & presentations on using Sotalol IV.


Listen in on conversations about Sotalol IV, antiarrhythmics, & other electrophysiology topics. Hosted by Dr. Eva Nelson, AltaThera Director Education & Training.

Get your questions answered

Virtual Office Hours

Have scientific or medical questions regarding the use of Sotalol IV? Click below to get into contact with our Education & Clinical teams, available via email correspondence or videoconference.

Contact Us

Highlights of Prescribing Information

Boxed Warning, Indications, and Important Safety Information


Sotalol can cause life threatening ventricular tachycardia associated with QT interval prolongation. To minimize the risk of drug induced arrhythmia, initiate or uptitrate intravenous sotalol in a facility that can provide continuous electrocardiographic monitoring and cardiac resuscitation [see Dosage and Administration (2.3) and Warnings and Precautions (5.1)].
Do not initiate intravenous sotalol therapy if the baseline QTc is longer than 450 ms. If the QTc prolongs to 500 ms or greater, reduce the dose or discontinue. (2.3)